Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial

Clinical trial NCT06580002 · RECRUITING

Trial details

NCT number: NCT06580002
Sponsor: University of California, Irvine
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Cancer Sarcoma Gastric Cancer Lung Cancer Head and Neck Cancer Colorectal Cancer Ovarian Cancer Liver Cancer Genitourinary Cancer Gynecologic Cancer Urinary Bladder Cancer Leukemia

Start date: 2024-12-02
Primary completion: 2027-07-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.